Frank\u00adfurt am Main \u2014 A team from the law firm HEUKING has advi\u00adsed Harald Quandt Indus\u00adtrie\u00adbe\u00adtei\u00adli\u00adgun\u00adgen GmbH (HQIB) on the acqui\u00adsi\u00adtion of Insti\u00adtut Virion Serion GmbH and its Chinese joint venture (Virion\\Serion). Virion\\Serion has been active in the deve\u00adlo\u00adp\u00adment, manu\u00adfac\u00adture and distri\u00adbu\u00adtion of in-vitro diagno\u00adstics (IVD) for the diagno\u00adsis of viral, bacte\u00adrial, fungal and para\u00adsi\u00adtic dise\u00ada\u00adses for over 45 years. As a global supplier, the company offers both raw mate\u00adri\u00adals and diagno\u00adstic products. These are used by over 400 custo\u00admers, mainly labo\u00adra\u00adto\u00adries and rese\u00adarch insti\u00adtu\u00adtes, in more than 100 countries.<\/p>\n
HQIB acqui\u00adred Virion\\Serion with the aim of further deve\u00adlo\u00adping the medium-sized company in the long term. The main focus is on the further expan\u00adsion of the raw mate\u00adri\u00adals area and further inter\u00adna\u00adtio\u00adna\u00adliza\u00adtion. With the help of HQIB\u2019s finan\u00adcial resour\u00adces and exper\u00adtise, stra\u00adte\u00adgic acqui\u00adsi\u00adti\u00adons of comple\u00admen\u00adtary tech\u00adno\u00adlo\u00adgies and product groups should further acce\u00adle\u00adrate growth. The manage\u00adment team around CEO Dr. Judith St\u00fcr\u00admer<\/strong> will remain with Virion\\Serion beyond the transaction.<\/p>\n About HQIB <\/strong><\/p>\n As an invest\u00adment holding company, HQIB invests in small and medium-sized compa\u00adnies in German-spea\u00adking count\u00adries that are active in estab\u00adlished, future-orien\u00adted and tech\u00adni\u00adcally sophisti\u00adca\u00adted sectors with attrac\u00adtive growth poten\u00adtial. The focus is on the areas of secu\u00adrity, digi\u00adta\u00adliza\u00adtion and health. HQIB holds invest\u00adments in a total of 23 compa\u00adnies. As an indus\u00adtrial holding company, HQIB pursues a long-term and sustainable invest\u00adment approach and is not subject to any matu\u00adrity rest\u00adric\u00adtions or limi\u00adted holding periods.<\/p>\n Advi\u00adsor Harald Quandt Indus\u00adtrie\u00adbe\u00adtei\u00adli\u00adgun\u00adgen GmbH: <\/strong>HEUKING<\/strong><\/p>\n Dr. P\u00e4r Johans\u00adson, photo (\u00a9 Heuking), lead part\u00adner (corpo\u00adrate law \/ M&A), Frank\u00adfurt am Main \u2014 A team from the law firm HEUKING has advi\u00adsed Harald Quandt Indus\u00adtrie\u00adbe\u00adtei\u00adli\u00adgun\u00adgen GmbH (HQIB) on the acqui\u00adsi\u00adtion of Insti\u00adtut Virion Serion GmbH and its Chinese joint venture (Virion\\Serion). Virion\\Serion has been active in the deve\u00adlo\u00adp\u00adment, manu\u00adfac\u00adture and distri\u00adbu\u00adtion of in-vitro diagno\u00adstics (IVD) for the diagno\u00adsis of viral, bacte\u00adrial, fungal and parasitic [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":50894,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1365,1366,1367,1368,1369],"tags":[],"class_list":["post-50896","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-private-equity-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-investors"],"yoast_head":"\n
\nMarkus Schm\u00fcl\u00adl\u00ading (labor law),
\nDr. Verena Hoene, LL.M. (IP, Media & Technology),
\nKris\u00adtina Schnei\u00adder, LL.M. (corpo\u00adrate law \/ M&A), all Cologne,
\nDr. Henrik Lay (tax law), Hamburg,
\nDr. Katha\u00adrina Pras\u00aduhn (Corpo\u00adrate Law \/ M&A), Munich,
\nDr. Chris\u00adtoph Schork, LL.M. (Corpo\u00adrate Law \/ M&A), Cologne<\/p>\n","protected":false},"excerpt":{"rendered":"